Shionogi & Co Ltd

General

Total Cases65
Active Cases6
Patents704
TypeOperating Company
Elite Ratings
--

Ratings

Experience
Grade
Trend
DCT
L3
A
PTAB
L2
B
CAFC
--
--
--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
09/16/24
[SEALED] Letter to The Honorable Sherry R. Fallon from Karen E. Keller regarding Amendment of Defendants' Answer and Counterclaims. (Attachments: # [1] Exhibit 1, # [2] Exhibit 2, # [3] Exhibit 3, # [4] Exhibit 4, # [5] Exhibit 5, # [6] Exhibit 6, # [7] Exhibit 7, # [8] Exhibit 8)(Keller, Karen) Modified on 9/16/2024 (lih). (Entered: 09/16/2024)
08/07/24
Case Assigned to Judge Mitchell S. Goldberg of the United States District Court for the Eastern District of Pennsylvania, due to related cases. Please include the initials of the Judge (MSG) after the case number on all documents filed. (rjb) (Entered: 08/07/2024)
08/02/24
DECLARATION of Service of Complaint and related papers to defendant Hetero USA Inc. by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Joyce, Alexandra) (Entered: 08/02/2024)
08/02/24
DECLARATION of Service of Complaint and related papers on Defendant Hetero Labs Limited by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Joyce, Alexandra) (Entered: 08/02/2024)
08/02/24
DECLARATION of Service of Complaint and related papers on Defendant Hetero Labs Limited Unit-III by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Joyce, Alexandra) (Entered: 08/02/2024)
08/02/24
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc., Corporate Parent GlaxoSmithKline plc., Corporate Parent Shionogi Limited, Other Affiliate The Bank of New York Mellon, Other Affiliate Shionogi & Co., Ltd. for ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited filed by ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (mws) (Entered: 08/02/2024)
08/02/24
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Shionogi & Co., Ltd. (mws) (Entered: 08/02/2024)
08/02/24
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,242,986; 11,234,985. (mws) (Entered: 08/02/2024)
08/02/24
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 06/20/2024. Date of Expiration of Patent: See Attached. Thirty Month Stay Deadline: 12/20/2026. (mws) (Entered: 08/02/2024)
08/02/24
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mws) (Entered: 08/02/2024)